Diversified Biotech Group, Inc. Introduces InvestBio Web Site - Promising Research Section; Publishers of InvestBio Report Add Online Health Hub to Web Site.Business/Finance/Internet Editors NEW YORK--(BUSINESS WIRE)--May 22, 2002 Diversified Biotech Group, Inc. (DBGI), a majority owned subsidiary of InvestPrivate Holdings Corporation, today announced the introduction of InvestBio(R) website's Promising Research section. The Promising Research section allows viewers the opportunity to inform and educate themselves on the latest developments and breakthroughs regarding all major diseases, lifestyles and biotechnology research. Diseases covered include Alzheimer's, Arthritis, Cancer, Heart Disease, Parkinson's and more. "Millions of people are either affected by or know someone who is affected by disease," stated Scott L. Mathis, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "When someone is faced with a diagnosis of a life-threatening illness, they expect the worst. With today's advances in biotechnology and medicine, there is a lot of positive news in terms of disease treatment and management. The InvestBio(R) Promising Research section was created for this purpose. As an online health hub, it provides our viewers with the most up-to-date news on different breakthroughs and advances for various diseases." DBGI's goal is to identify the companies that currently have the most promising research in development, as these companies may offer investors the potential to build wealth. Some companies with recent advances in medical research include Allos Therapeutics (ALTH), currently in clinical trials for lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. treatment and metastatic Metastatic The term used to describe a secondary cancer, or one that has spread from one area of the body to another. Mentioned in: Coagulation Disorders metastatic pertaining to or of the nature of a metastasis. brain cancer; Biotransplant (BTRN), currently in trials for treatment of cancer, autoimmune disease autoimmune disease, any of a number of abnormal conditions caused when the body produces antibodies to its own substances. In rheumatoid arthritis, a group of antibody molecules called collectively RF, or rheumatoid factor, is complexed to the individual's own gamma , and organ transplant; and Millennium (MLNM) with its advances in cancer and cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease . About Diversified Biotech Group, Inc.: Diversified Biotech Group, Inc., a majority owned subsidiary of InvestPrivate Holdings Corporation, was created to pursue the most promising opportunities in biotechnology through publishing, venture capital, and advisory services advisory services advisory services provided to the public, in their capacity as owners and managers of animals, are an important part of veterinary science. They may be provided by government bureaux, by commercial companies who deal in pharmaceuticals or animals or animal . DBGI is building the bridge that will allow individual investors access to easy-to-understand information and financial opportunities in the biotechnology sector. DBGI is headquartered at 500 Fifth Avenue, 56th Floor, New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , NY 10110. The Company's telephone and fax numbers are 212.739.7700 and 212.655.0140 respectively. Its website is www.investbio.com Important Notes: The Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 provides a safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. for forward-looking statements. This press release may contain certain statements of a forward-looking nature relating to future events or future business performance. Any such statements that refer to the Company's estimated or anticipated future results or other non-historical facts are forward-looking and reflect the Company's current perspective of existing trends and information. These statements involve risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. The forward-looking statements speak only as of the date of this release. The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion